Canadian Liver Journal
Scope & Guideline
Empowering Knowledge for Liver Health.
Introduction
Aims and Scopes
- Hepatitis Management and Research:
The journal emphasizes research on hepatitis viruses, including hepatitis B and C, focusing on epidemiology, treatment efficacy, and elimination strategies. - Liver Transplantation and Eligibility:
A core area is the study of liver transplantation, including recipient selection, eligibility criteria, and outcomes, reflecting the evolving practices in transplant medicine. - Impact of Lifestyle on Liver Health:
Research focusing on lifestyle factors affecting liver health, such as alcohol use, diet, and exercise, is prevalent, indicating the journal's commitment to preventive hepatology. - Health Disparities and Access to Care:
The journal addresses disparities in liver disease management, particularly among Indigenous populations and marginalized communities, highlighting the need for equitable healthcare access. - Innovative Therapies and Treatment Approaches:
There is a strong focus on novel therapeutic approaches, including direct-acting antivirals for hepatitis C and other emerging treatments for liver diseases. - Public Health and Policy Implications:
The journal includes studies that examine the public health implications of liver diseases and the effectiveness of health policies aimed at improving liver health outcomes.
Trending and Emerging
- Telehealth and Digital Health Solutions:
There is an increasing interest in the role of digital health interventions, such as app-based solutions for managing liver disease, reflecting broader trends in healthcare technology. - Intersection of Hepatology and Mental Health:
Emerging research explores the psychological aspects of liver diseases, including mental health outcomes for patients with chronic liver conditions, highlighting the need for holistic care. - Inclusive Research Practices:
A growing emphasis on inclusivity in research methodologies, particularly involving Indigenous populations and other marginalized groups, is evident, aiming to address health disparities. - COVID-19 Impact on Liver Health:
The journal has seen an uptick in studies examining the intersection of liver disease management and the COVID-19 pandemic, focusing on its implications for treatment and healthcare access. - Integration of Multidisciplinary Approaches:
Recent papers highlight the integration of various specialties in liver care, emphasizing collaborative approaches that include gastroenterology, nutrition, and mental health. - Focus on Non-Alcoholic Fatty Liver Disease (NAFLD):
Research on NAFLD and its associated metabolic disorders is increasingly prominent, reflecting the rising prevalence of these conditions and their implications for public health.
Declining or Waning
- Case Studies and Anecdotal Reports:
There has been a noticeable decline in the publication of individual case studies, indicating a potential shift towards more comprehensive cohort studies and systematic reviews. - Traditional Hepatitis Treatment Protocols:
Research focusing on older treatment methods for hepatitis, such as interferon therapies, appears to be waning in favor of studies on newer direct-acting antiviral agents. - General Reviews without New Insights:
The frequency of purely descriptive reviews without significant new findings or insights has decreased, as the journal seeks more innovative and impactful contributions. - Focus on Rare Liver Diseases:
While rare liver diseases are still relevant, papers specifically addressing these conditions have diminished, possibly indicating a preference for more common and impactful liver conditions. - Pharmacological Studies of Established Drugs:
The exploration of well-established pharmacological treatments for liver diseases has seen a decline, suggesting a shift towards novel therapies and research methodologies.
Similar Journals
International Journal of Hepatology
Unveiling critical research to transform liver care.The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Driving excellence in gastrointestinal and liver disease studies.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
Clinical Gastroenterology and Hepatology
Elevating Standards in Gastroenterology and HepatologyClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
JOURNAL OF HEPATOLOGY
Leading the Way in Hepatic Health DiscoveriesJOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.
HEPATOLOGY RESEARCH
Pioneering studies that transform the landscape of Hepatology.Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.
Gut and Liver
Elevating standards in Gastroenterology and Hepatology.Gut and Liver is a prestigious peer-reviewed journal dedicated to advancing the fields of Gastroenterology and Hepatology. Published by the EDITORIAL OFFICE GUT & LIVER in South Korea, this Open Access journal has been disseminating valuable research findings since 2007, making critical knowledge accessible to a global audience. With an impressive 2023 impact factor that places it in Q1 rank in both Gastroenterology (#28/167) and Hepatology (#22/82), it is recognized as a leader in the medical domain. The journal covers diverse topics, including innovative therapeutic strategies, clinical practices, and groundbreaking research in liver diseases and gastrointestinal disorders, thereby playing a vital role in improving patient care and outcomes. Researchers, healthcare professionals, and students can benefit from the journal's wealth of information, designed to foster collaboration and spark new ideas within the scientific community. For further engagement with current research, readers can access issues from 2009 to 2024 and stay updated on the latest advancements in the field.
HEPATOLOGY
Transforming liver health with groundbreaking insights.HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.
Korean Journal of Gastroenterology
Uniting Experts for Enhanced Digestive Health SolutionsKorean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.
Gastroenterologia y Hepatologia
Advancing knowledge in gastrointestinal and liver health.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.
Annals of Hepatology
Connecting researchers and clinicians in the quest for liver health.Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.